美通社

2024-09-26 21:00

IFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024

NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development.

"We are unveiling groundbreaking technologies that refine polymer expertise, tackling critical industry challenges head-on and empowering our customers to achieve unparalleled success," said Angela Strzelecki, President, Pharma Solutions, IFF. "As we mark over 75 years of market leadership as a market leading excipient manufacturer, we invite visitors to join us to witness this transformative journey with us."

Low nitrite excipient solutions

Nitrosamine risk mitigation will take center stage at booth 6B10, where IFF will unveil its expanding portfolio of solutions for nitrosamine control. Avicel® PH Low Nitrite (LN) is a range of low nitrite microcrystalline cellulose (MCC) grades demonstrated to reduce the risk of nitrosamine formation as part of broader mitigation strategies. IFF's expertise in this space also extends to its well-established METHOCEL™ family of products. The Company will spotlight how its advanced analytical method leverages highly sensitive ion chromatography-mass spectrometry (IC/MS) to detect nitrites at trace levels down to parts per billion (ppb) in its METHOCEL™ grades. Furthermore, attendees can look forward to an exclusive preview of IFF's upcoming low nitrite addition.

Supporting breakthroughs in biotech 

Demonstrating its contribution to the future of biotechnology, IFF will present its expanding ultrapure alginate technologies at CPHI. NOVAMATRIX-3D™, part of the NovaMatrix® product portfolio, is an animal-free 3D cell culture system engineered for efficient cell seeding and enzyme-free cell release. It offers a more physiologically relevant environment than traditional 2D cultures, supporting various cell lines and opening new possibilities for drug development, cancer research, tissue engineering, toxicity testing and stem cell research. IFF will also showcase PRONOVA® UP CAM, a specialized ultrapure calcium alginate allowing for controlled and in-situ gelation across diverse biomedical applications, from cell and drug encapsulation systems to advanced wound dressings and tissue engineering. 

New horizons with POLYOX™ ES packaging

In addition to its biopolymer solutions, IFF will introduce new foil bag-in-box packaging for its POLYOX™ water-soluble resins (WSR). The packaging extends the stability of POLYOX™ WSR by providing a moisture and oxygen barrier to preserve polymer viscosity, improving the product's storage life and supporting more effective supply chain and inventory management practices. The packaging is also more easily recyclable than fiber drums providing more than 85 percent reduction in landfill waste associated with POLYOX™ WSR packaging to support customers' sustainability initiatives.

Join IFF's experts to learn how the Company's expanding capabilities continue to optimize drug product formulation and drive innovation forward, visit booth 6B10 or schedule an appointment here.

Welcome to IFF

At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, X (Twitter) , FacebookInstagram, and LinkedIn.

©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with TM, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

source: IFF

【你點睇?】美國總統特朗普批評烏克蘭總統澤連斯基是「一位未經選舉的獨裁者」,俄烏戰爭早應停止。你是否認同特朗普的說法?► 立即投票

人氣文章
最近7天
1
港股 | 蕭猷華:內地AI發展迅速,阿里巴巴股價看俏
2
高息定存 | 一周高息合集,銀行高息搶存,富邦1個月4.88厘,華僑1年期3.6厘
3
PapaHome淘寶家具實體店22日開幕,選址尖沙咀中港城,料創100個就業機會
4
高息定存 | 華僑銀行推新春港元定存優惠,88天或188天享3.68厘
5
英偉達 | DeepSeek衝擊AI晶片行業結構 英偉達暴跌仍未急抄底
6
高息定存 | 一周高息合集,蛇年定存金蛇起舞,1個月定存高達8厘
7
啟德體育園明天足球賽測試,4.4萬公僕參與涉逾400萬車馬費
8
電騙 | 黃俊碩:多管齊下,防治內地留學生受騙
9
環球央行 | 歐洲央行宣布再次減息0.25厘,符合市場預期
10
一本萬利 | 2025年的五個「勿」(有片)
11
易經看世界 | 乙巳蛇年趨吉五招:言行注意甚麼?應遠離甚麼人?(有片)
12
專訪 | 關稅戰 | 香港物流協會副會長梁庭彰:美物流商停收包裹對跨境電商打擊重大
13
高息定存 | 一周高息合集,減息預期降溫,銀行3個月最高5.68厘,6個月3.55厘
14
港股 | 午市前瞻 | iPhone SE難救中國市場 專家提醒比電已超買
15
【FOCUS】螺絲殼裏做道場,DeepSeek致勝啟示
16
大S | 台灣藝人徐熙媛因流感併發肺炎逝世,享年48歲
17
DeepSeek推出即上蘋果中國區榜首,能力直追OpenAI
18
【FOCUS】悟空、哪吒、DeepSeek,如何啟示香港
19
日入而息 | 習近平據報下周見科企領袖,證監會審視8券商孖展風控,大酒店轉蝕9億
20
收市短打 | 楊韻銳:港股升勢有成交配合 惟留意關鍵阻力位!
21
新世界 | 摩通:新世界若債務違約或打開行業「潘朵拉盒子」
22
港股 | 午市前瞻 | AI應用概念炒作有錢途 下階段部署邊隻好?
23
【FOCUS】侵侵呼籲全球「降息」,日銀祭18年最激進加息
24
彭博亞洲20大富裕家族,香港5大家族上榜,新地郭氏排名最高,無李嘉誠李兆基?
25
港股 | 蕭猷華:春節假後,恒指逐步上望21000點
26
高息定存 | 信銀國際12個月港元定存高達3.5厘
27
神州經脈 | 特朗普或與華討論關稅,人民幣大漲,滬指連升兩周
28
David Webb:因病情惡化,將有序結束個人財經網站
29
民營企業座談會 | 習近平在京出席民營企業座談會
30
AI | 蔡崇信確認阿里與蘋果合作,撰文談DeepSeek崛起帶來兩大啟示
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

etnet榮膺「第九屆傳媒轉型大獎」四大獎項

【限時優惠$68/月】申請etnet強化版MQ手機串流報價服務 捕捉板塊輪動,提高獲利勝算

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

2025-26年度財政預算案

大國博弈

貨幣攻略

說說心理話

Watch Trends 2024

北上食買玩

Art Month 2024

理財秘笈

流感高峰期

山今養生智慧

輕鬆護老